中商官网
研究报告
绿叶制药（HK2186）
| 科目\年度 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 现金及现金等价物净增加额 |
165276.50 | 101882.80 | 4963.60 | -137476.40 | 142562.70 | 63751.80 | 45248.50 | 95298.30 | -42285.40 | 68633.60 | -18187.90 | -2743.00 | 10928.90 |
| 经营活动现金流量净额 |
16776.40 | 159548.70 | 165379.60 | 18237.10 | 103344.90 | 142262.90 | 104558.70 | 96410.20 | 59202.80 | 39470.80 | 49456.60 | 43861.80 | 15290.20 |
| 投资活动现金流量净额 |
-147125.60 | -141825.80 | -165830.80 | -343603.20 | 13819.70 | -262870.50 | -299774.80 | -74369.60 | -183489.50 | 24031.80 | -315878.70 | -55336.80 | -13513.00 |
| 融资活动现金流量净额 |
295625.70 | 84159.90 | 5414.80 | 187889.70 | 25398.10 | 184359.40 | 240464.60 | 73257.70 | 82001.30 | 5131.00 | 248234.20 | 8732.00 | 9151.70 |
| 现金及现金等价物期末余额 |
493714.50 | 323897.30 | 232374.00 | 243825.20 | 386538.50 | 232734.90 | 167286.50 | 126587.20 | 39777.50 | 84367.40 | 15186.30 | 33315.00 | 36403.10 |
| 经营活动现金流量净额 |
16776.40 | 159548.70 | 165379.60 | 18237.10 | 103344.90 | 142262.90 | 104558.70 | 96410.20 | 59202.80 | 39470.80 | 49456.60 | 43861.80 | 15290.20 |
| 折旧与摊销 |
79067.20 | 70185.10 | 67131.30 | 58198.20 | 51089.90 | 45566.00 | 31718.50 | 24978.70 | 14092.00 | 11520.90 | 11073.70 | 10093.40 | 8407.00 |
| 营运资金变动 |
-123375.40 | 39798.80 | 31979.20 | -41808.20 | -30032.80 | -48569.40 | -48615.10 | -11361.40 | -30844.60 | -41021.20 | -20007.60 | 3808.20 | -10598.50 |
| 投资活动现金流量净额 |
-147125.60 | -141825.80 | -165830.80 | -343603.20 | 13819.70 | -262870.50 | -299774.80 | -74369.60 | -183489.50 | 24031.80 | -315878.70 | -55336.80 | -13513.00 |
| 资本性支出 |
170849.70 | 116526.10 | 116365.90 | 154159.50 | 151988.30 | 305096.20 | 248451.50 | 62518.20 | 31914.10 | 20809.20 | 28927.50 | 27092.30 | 14706.50 |
| 投资购买 |
-174434.10 | -160264.70 | -262709.90 | -369680.50 | -285922.00 | -337947.70 | -- | -460601.00 | -455400.00 | -513872.00 | -184046.50 | -1000.00 | -- |
| 融资活动现金流量净额 |
295625.70 | 84159.90 | 5414.80 | 187889.70 | 25398.10 | 184359.40 | 240464.60 | 73257.70 | 82001.30 | 5131.00 | 248234.20 | 8732.00 | 9151.70 |
| 股份回购 |
-- | -- | -- | -- | -7796.20 | -877.60 | -2160.50 | -46199.30 | -- | -- | -- | -- | -- |
| 支付股息 |
-- | -550.00 | -1100.00 | -- | -18548.70 | -37740.90 | -29492.10 | -21791.10 | -11154.40 | -456.80 | -761.30 | -1218.00 | -- |
| 股票发行 |
22952.70 | 69630.50 | 18915.60 | 104447.70 | -- | -- | -- | -- | -- | -- | 313934.00 | -- | -- |
| 现金及现金等价物净增加额 |
165276.50 | 101882.80 | 4963.60 | -137476.40 | 142562.70 | 63751.80 | 45248.50 | 95298.30 | -42285.40 | 68633.60 | -18187.90 | -2743.00 | 10928.90 |
| 加：现金及现金等价物期初余额 |
323897.30 | 232374.00 | 243825.20 | 386538.50 | 232734.90 | 169736.30 | 126587.20 | 39777.50 | 84367.40 | 15186.30 | 33315.00 | 36403.10 | 25150.10 |
| 汇率变动对现金及现金等价物的影响 |
4540.70 | -10359.50 | -16414.80 | -5236.90 | 11240.90 | -753.20 | -4549.20 | -8488.60 | -2304.50 | 547.50 | 59.20 | -345.10 | 324.10 |
| 现金及现金等价物期末余额 |
493714.50 | 323897.30 | 232374.00 | 243825.20 | 386538.50 | 232734.90 | 167286.50 | 126587.20 | 39777.50 | 84367.40 | 15186.30 | 33315.00 | 36403.10 |